top of page
CoLumbo reads spine MRI scans to provide a pre-populated report. The software reduces the total interpretation time by up to 48% and reduces errors of omission by up to 15%. CoLumbo has a CE mark, FDA 510(K), and TGA clearance. The key novelty of CoLumbo lies in the unique machine learning algorithm, based on fully convolutional neural networks combined with medical domain knowledge.
Status
Active
Sector:
HealthTech
Year invested
2023
Stage invested
Start-up
Website: https://columbo.me/
bottom of page